44
Views
54
CrossRef citations to date
0
Altmetric
Cell Growth and Development

MyoD-Dependent Induction during Myoblast Differentiation of p204, a Protein Also Inducible by Interferon

, , , , , , , , & show all
Pages 7024-7036 | Received 18 Feb 2000, Accepted 21 Jun 2000, Published online: 28 Mar 2023
 

Abstract

p204, an interferon-inducible p200 family protein, inhibits rRNA synthesis in fibroblasts by blocking the binding of the upstream binding factor transcription factor to DNA. Here we report that among 10 adult mouse tissues tested, the level of p204 was highest in heart and skeletal muscles. In cultured C2C12 skeletal muscle myoblasts, p204 was nucleoplasmic and its level was low. During myoblast fusion this level strongly increased, p204 became phosphorylated, and the bulk of p204 appeared in the cytoplasm of the myotubes. Leptomycin B, an inhibitor of nuclear export that blocked myoblast fusion, inhibited the nuclear export signal-dependent translocation of p204 to the cytoplasm. The increase in the p204 level during myoblast fusion was a consequence of MyoD transcription factor binding to several MyoD-specific sequences in the gene encoding p204, followed by transcription. Overexpression of p204 (in C2C12 myoblasts carrying an inducible p204 expression plasmid) accelerated the fusion of myoblasts to myotubes in differentiation medium and induced the fusion even in growth medium. The level of p204 in mouse heart muscle strongly increased during differentiation; it was barely detectable in 10.5-day-old embryos, reached the peak level in 16.5-day-old embryos, and remained high thereafter. p204 is the second p200 family protein (after p202a) found to be involved in muscle differentiation. (p202a was formerly designated p202. The new designation is due to the identification of a highly similar protein—p202b [H. Wang, G. Chatterjee, J. J. Meyer, C. J. Liu, N. A. Manjunath, P. Bray-Ward, and P. Lengyel, Genomics 60:281–294, 1999].) These results reveal that p204 and p202a function in both muscle differentiation and interferon action.

ACKNOWLEDGMENTS

We thank M. Yoshida and C. Brennan for leptomycin B, C. Weissmann and H. Weber for human α21 interferon (1-83), A. Lassar for the pCMV-MyoD and GST-MyoD plasmids, T. Koleske for instruction in obtaining timed-pregnant mice, S. Wolin for the use of a 2-D gel electrophoresis system, and L. Vellali for preparing the manuscript for publication.

These studies were supported by NIH research grants R37AI12320 to P.L. and HG02153 to B.A.R. and by a postdoctoral fellowship to H.W. from the Cancer Research Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.